Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis
Igor Snast, Ofer Reiter, Emmilia Hodak, et al.
American Journal of Clinical Dermatology (2017) Vol. 19, Iss. 2, pp. 145-165
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Pathophysiology of atopic dermatitis: Clinical implications
Jihyun Kim, Byung Eui Kim, Donald Y.M. Leung
Allergy and Asthma Proceedings (2019) Vol. 40, Iss. 2, pp. 84-92
Open Access | Times Cited: 471
Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis
Byong Seung Cho, Jin Ock Kim, Dae Hyun Ha, et al.
Stem Cell Research & Therapy (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 260
First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis
Ian A. Myles, Noah Earland, Erik D. Anderson, et al.
JCI Insight (2018) Vol. 3, Iss. 9
Open Access | Times Cited: 257
Eosinophils from Physiology to Disease: A Comprehensive Review
Giuseppe A. Ramirez, Mona‐Rita Yacoub, Marco Ripa, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-28
Open Access | Times Cited: 247
Dupilumab-induced psoriasis in a patient with atopic dermatitis successfully treated with Upadacitinib: A case report
Katrina Cirone, Fiona Lovegrove
SAGE Open Medical Case Reports (2025) Vol. 13
Open Access | Times Cited: 2
Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches
Matthew Moyle, Ferda Cevikbas, Jamie L. Harden, et al.
Experimental Dermatology (2019) Vol. 28, Iss. 7, pp. 756-768
Open Access | Times Cited: 140
Dupilumab: A New Paradigm for the Treatment of Allergic Diseases
J. Sastre, Ignacio Dávila
Journal of Investigational Allergology and Clinical Immunology (2018) Vol. 28, Iss. 3, pp. 139-150
Open Access | Times Cited: 119
Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis
Doreen Siegels, Annice Heratizadeh, Susanne Abraham, et al.
Allergy (2020) Vol. 76, Iss. 4, pp. 1053-1076
Open Access | Times Cited: 95
Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair
Ian A. Myles, Carlo R. Castillo, Kent Barbian, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 560
Open Access | Times Cited: 91
Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre
Caroline Meyer Olesen, Jesper Grønlund Holm, Line Brok Nørreslet, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. 8, pp. 1562-1568
Closed Access | Times Cited: 85
Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options
Thomas Bieber, Amy S. Paller, Kenji Kabashima, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 9, pp. 1432-1449
Open Access | Times Cited: 55
Strategies for using topical corticosteroids in children and adults with eczema
S. Lax, Jane Harvey, Emma Axon, et al.
Cochrane library (2022) Vol. 2022, Iss. 3
Open Access | Times Cited: 54
Systemic treatments for eczema: a network meta-analysis
Ratree Sawangjit, Piyameth Dilokthornsakul, Antonia Lloyd-Lavery, et al.
Cochrane library (2020) Vol. 2020, Iss. 9
Open Access | Times Cited: 56
Efficacy and safety of dupilumab for moderate‐to‐severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
Ioana Agache, Yang Song, Margarita Posso, et al.
Allergy (2020) Vol. 76, Iss. 1, pp. 45-58
Open Access | Times Cited: 50
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
Eustachio Nettis, Luisa Brussino, Vincenzo Patella, et al.
Clinical and Molecular Allergy (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis
Raquel Leão Orfali, Valéria Aoki
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 577-577
Open Access | Times Cited: 21
Biological therapies for atopic dermatitis: An update�(Review)
Diana Deleanu, Irena Nedelea
Experimental and Therapeutic Medicine (2018)
Open Access | Times Cited: 58
Phenotypes and endotypes in eosinophilic esophagitis
Melanie A. Ruffner, Antonella Cianferoni
Annals of Allergy Asthma & Immunology (2019) Vol. 124, Iss. 3, pp. 233-239
Open Access | Times Cited: 49
What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study*
Jonathan I. Silverberg, Donald Lei, Muhammad Yousaf, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 5, pp. 888-895
Open Access | Times Cited: 48
Mesenchymal Stem Cells and Atopic Dermatitis: A Review
Sérgio Ricardo Teixeira Daltro, Cássio Santana Meira, Ivanilson Pimenta Santos, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 41
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
Panteha Eshtiaghi, Melinda Gooderham
Core evidence (2018) Vol. Volume 13, pp. 13-20
Open Access | Times Cited: 40
NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation
Gemma Carreras‐Badosa, Julia Maslovskaja, Kapilraj Periyasamy, et al.
Biomaterials (2020) Vol. 262, pp. 120316-120316
Open Access | Times Cited: 39
EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2020) Vol. 76, Iss. 4, pp. 988-1009
Open Access | Times Cited: 37
Consensus Update for Systemic Treatment of Atopic Dermatitis
Ji Hyun Lee, Jung Eun Kim, Gyeong‐Hun Park, et al.
Annals of Dermatology (2021) Vol. 33, Iss. 6, pp. 497-497
Open Access | Times Cited: 27
Incidence of upper respiratory tract infections with biological therapies in moderate to severe atopic dermatitis: a systematic review and meta-analysis
Rose Alraddadi, Mulham Kalantan, Yara Aljefri, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Page 1 - Next Page

Scroll to top